{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:10:48Z","timestamp":1771877448095,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100012754","name":"Horizon Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012754","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1396-8","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T11:43:53Z","timestamp":1502970233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout"],"prefix":"10.1186","volume":"19","author":[{"given":"Leonard H.","family":"Calabrese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony E.","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Lipsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"1396_CR1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/art.22403","volume":"56","author":"JS Sundy","year":"2007","unstructured":"Sundy JS, Ganson NJ, Kelly SJ, Scarlett EL, Rehrig CD, Huang W, et al. Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout. Arthritis Rheum. 2007;56:1021\u20138.","journal-title":"Arthritis Rheum"},{"key":"1396_CR2","unstructured":"KRYSTEXXA\u2122 (pegloticase) Injection, for intravenous infusion. 2016. Available from: \nhttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/125293s0000lbl.pdf\n\n. Accessed 3 Aug 2017."},{"key":"1396_CR3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1617","volume":"306","author":"JS Sundy","year":"2011","unstructured":"Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA. 2011;306:711\u201320.","journal-title":"JAMA"},{"key":"1396_CR4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/RHU.0000000000000200","volume":"20","author":"HS Barah","year":"2014","unstructured":"Barah HS, Yood RA, Ottery FD, Sundy JS, Becker MA. Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy. J Clin Rheumatol. 2014;20:427\u201332.","journal-title":"J Clin Rheumatol"},{"key":"1396_CR5","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar4497","volume":"16","author":"PE Lipsky","year":"2014","unstructured":"Lipsky PE, Calabrese LH, Kavanaugh A, Sundy JS, Wright D, Wolfson M, et al. Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout. Arthritis Res Ther. 2014;16:R60.","journal-title":"Arthritis Res Ther"},{"key":"1396_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12245-009-0093-z","volume":"2","author":"V Manivannan","year":"2009","unstructured":"Manivannan V, Decker WW, Stead LG, Li JT, Campbell RL. Visual representation of National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network criteria for anaphylaxis. Int J Emerg Med. 2009;2:3\u20135.","journal-title":"Int J Emerg Med"},{"key":"1396_CR7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaci.2011.09.030","volume":"129","author":"RL Campbell","year":"2012","unstructured":"Campbell RL, Hagan JB, Manivannan V, Decker WW, Kanthala AR, Bellolio MF, et al. Evaluation of national institute of allergy and infectious diseases\/food allergy and anaphylaxis network criteria for the diagnosis of anaphylaxis in emergency department patients. J Allergy Clin Immunol. 2012;129:748\u201352.","journal-title":"J Allergy Clin Immunol"},{"key":"1396_CR8","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jaip.2016.06.003","volume":"4","author":"CE Brauer","year":"2016","unstructured":"Brauer CE, Motosue MS, Li JT, Hagan JB, Bellolio MF, Lee S, et al. Prospective validation of the NIAID\/FAAN criteria for emergency department diagnosis of anaphylaxis. J Allergy Clin Immunol Pract. 2016;4:1220\u20136.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1396_CR9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","volume":"115","author":"P Lieberman","year":"2015","unstructured":"Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein D, Bernstein J, et al. Anaphylaxis\u2013a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115:341\u201384.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1396_CR10","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1136\/annrheumdis-2012-201795","volume":"72","author":"MA Becker","year":"2013","unstructured":"Becker MA, Baraf HS, Yood RA, Dillon A, V\u00e1zquez-Mellado J, Ottery FD, et al. Long-term safety of pegloticase in chronic gout refractory to conventional treatment. Ann Rheum Dis. 2013;72:1469\u201374.","journal-title":"Ann Rheum Dis"},{"key":"1396_CR11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jaci.2012.01.030","volume":"129","author":"CA Camargo Jr","year":"2012","unstructured":"Camargo Jr CA. Potter Stewart and the definition of anaphylaxis [editorial]. J Allergy Clin Immunol. 2012;129:753\u20134.","journal-title":"J Allergy Clin Immunol"},{"key":"1396_CR12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2044.2004.03757.x","volume":"59","author":"V Payne","year":"2004","unstructured":"Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia. 2004;59:695\u2013703.","journal-title":"Anaesthesia"},{"key":"1396_CR13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1742-6723.2004.00562.x","volume":"16","author":"SG Brown","year":"2004","unstructured":"Brown SG, Blackman KE, Heddle RJ. Can serum mast cell tryptase help diagnose anaphylaxis? Emerg Med Australas. 2004;16:120\u20134.","journal-title":"Emerg Med Australas"},{"key":"1396_CR14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000339749","volume":"160","author":"A Sala-Cunill","year":"2013","unstructured":"Sala-Cunill A, Cardona V, Labrador-Horrillo M, Luengo O, Esteso O, Garriga T, et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol. 2013;160:192\u20139.","journal-title":"Int Arch Allergy Immunol"},{"key":"1396_CR15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0091-6749(75)90094-9","volume":"56","author":"H Tannenbaum","year":"1975","unstructured":"Tannenbaum H, Ruddy S, Schur PH. Acute anaphylaxis associated with serum complement depletion. J Allergy Clin Immunol. 1975;56:226\u201334.","journal-title":"J Allergy Clin Immunol"},{"issue":"6 Suppl","key":"1396_CR16","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/00004424-198011001-00004","volume":"15","author":"EC Lasser","year":"1980","unstructured":"Lasser EC, Lang JH, Lyon SG, Hamblin AE. Changes in complement and coagulation factors in a patient suffering a severe anaphylactoid reaction to injected contrast material: some considerations of pathogenesis. Invest Radiol. 1980;15(6 Suppl):S6\u201312.","journal-title":"Invest Radiol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1396-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T04:59:36Z","timestamp":1589777976000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1396-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1396"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1396-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]},"article-number":"191"}}